isomethyleugenol has been researched along with Malignant Mesothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, J; Bushell, M; Chernova, T; Dinsdale, D; Donaldson, K; Dudek, KM; Galavotti, S; Greaves, P; Grosso, S; Le Quesne, J; MacFarlane, M; Murphy, FA; Nakas, A; Poland, CA; Powley, IR; Schinwald, A; Sun, XM; Willis, AE; Zacarias-Cabeza, J | 1 |
| Fennell, D; Habib, T; Jithesh, PV; Manente, AG; Moro, L; Nilsson, S; Pinton, G; Tavian, D; Zonca, S | 1 |
2 other study(ies) available for isomethyleugenol and Malignant Mesothelioma
| Article | Year |
|---|---|
Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf).
Topics: Aged; Animals; Asbestos; Carcinogenesis; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p19; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Methylation; Mice; Mice, Inbred C57BL; Middle Aged; Nanotubes, Carbon | 2017 |
KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.
Topics: Basic Helix-Loop-Helix Transcription Factors; Cell Hypoxia; Cell Line, Tumor; Epigenesis, Genetic; Estrogen Receptor beta; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Methylation; Protein Processing, Post-Translational | 2016 |